# MOGAT2

## Overview
MOGAT2, or monoacylglycerol O-acyltransferase 2, is a gene that encodes an enzyme involved in lipid metabolism, specifically categorized as an acyltransferase. The enzyme plays a pivotal role in the synthesis of diacylglycerol from monoacylglycerol and fatty acyl-CoA, a critical step in the biosynthesis of triglycerides, which are essential for energy storage and lipid homeostasis (Cao2003Cloning). MOGAT2 is predominantly expressed in the endoplasmic reticulum of intestinal and adipose tissues, where it facilitates the reassembly of digested triacylglycerol, thereby aiding in dietary fat absorption (Gao2013Intestinespecific). The gene's expression and the enzyme's activity are crucial for maintaining metabolic efficiency and energy balance, with significant implications for conditions such as obesity and metabolic disorders (Yen2009Deficiency). Variations in MOGAT2 expression have been linked to differences in energy expenditure and body-fat percentage, highlighting its potential as a therapeutic target for metabolic diseases (Yen2009Deficiency).

## Function
MOGAT2 (monoacylglycerol O-acyltransferase 2) is an enzyme that plays a critical role in lipid metabolism, specifically in the synthesis of diacylglycerol (DAG) from monoacylglycerol (MAG) and fatty acyl-CoA. This process is essential for the biosynthesis of triglycerides, which are crucial for energy storage and lipid homeostasis in the body (Cao2003Cloning). MOGAT2 is primarily active in the endoplasmic reticulum of intestinal and adipose tissues, where it facilitates the reassembly of digested triacylglycerol, aiding in the absorption of dietary fat (Gao2013Intestinespecific).

In healthy human cells, MOGAT2's activity is vital for efficient dietary fat assimilation and energy metabolism. The enzyme's function in the intestine is particularly important, as it helps regulate the rate of fat absorption and contributes to overall metabolic efficiency (Gao2013Intestinespecific). MOGAT2's role in lipid metabolism also impacts systemic energy balance, influencing processes such as energy expenditure and fat storage. Its activity is linked to the regulation of metabolic efficiency, with implications for conditions like obesity and metabolic disorders (Yen2009Deficiency).

## Clinical Significance
Alterations in the expression of the MOGAT2 gene have significant clinical implications, particularly in the context of metabolic disorders. MOGAT2 is involved in the synthesis of triacylglycerol, a crucial process for dietary fat absorption. Mice deficient in MOGAT2 (Mogat2 -/-) are resistant to obesity and metabolic disorders induced by high-fat diets, despite absorbing normal amounts of dietary fat. These mice exhibit increased energy expenditure and decreased metabolic efficiency, suggesting that MOGAT2 plays a role in regulating systemic energy metabolism (Gao2013Intestinespecific; Nelson2011Deficiency).

In humans, variations in MOGAT2 expression are associated with differences in resting energy expenditure and body-fat percentage, indicating that changes in MOGAT2 expression could influence metabolic efficiency and susceptibility to weight gain (Yen2009Deficiency). The potential therapeutic implications of these findings suggest that inhibiting MOGAT2 could be a strategy for treating obesity and related metabolic diseases (Yen2009Deficiency).

Additionally, single nucleotide polymorphisms (SNPs) in the MOGAT2 gene have been linked to serum lipid levels and the risk of ischemic stroke. For instance, the rs11236530 SNP is associated with an increased risk of ischemic stroke and lower high-density lipoprotein cholesterol (HDL-C) levels (Zhou2021DGAT2MOGAT2).


## References


[1. (Gao2013Intestinespecific) Yu Gao, David W. Nelson, Taylor Banh, Mei-I Yen, and Chi-Liang Eric Yen. Intestine-specific expression of mogat2 partially restores metabolic efficiency in mogat2-deficient mice. Journal of Lipid Research, 54(6):1644–1652, June 2013. URL: http://dx.doi.org/10.1194/jlr.m035493, doi:10.1194/jlr.m035493. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.m035493)

[2. (Nelson2011Deficiency) David W. Nelson, Yu Gao, Nicole M. Spencer, Taylor Banh, and Chi-Liang Eric Yen. Deficiency of mgat2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain. Journal of Lipid Research, 52(9):1723–1732, September 2011. URL: http://dx.doi.org/10.1194/jlr.m016840, doi:10.1194/jlr.m016840. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.m016840)

[3. (Zhou2021DGAT2MOGAT2) Yong-Gang Zhou, Rui-Xing Yin, Feng Huang, Jin-Zhen Wu, Wu-Xian Chen, and Xiao-Li Cao. Dgat2-mogat2 snps and gene-environment interactions on serum lipid profiles and the risk of ischemic stroke. Frontiers in Cardiovascular Medicine, November 2021. URL: http://dx.doi.org/10.3389/fcvm.2021.685970, doi:10.3389/fcvm.2021.685970. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcvm.2021.685970)

[4. (Cao2003Cloning) Jingsong Cao, John Lockwood, Paul Burn, and Yuguang Shi. Cloning and functional characterization of a mouse intestinal acyl-coa:monoacylglycerol acyltransferase, mgat2. Journal of Biological Chemistry, 278(16):13860–13866, April 2003. URL: http://dx.doi.org/10.1074/jbc.m300139200, doi:10.1074/jbc.m300139200. This article has 115 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m300139200)

[5. (Yen2009Deficiency) Chi-Liang Eric Yen, Mei-Leng Cheong, Carrie Grueter, Ping Zhou, Junya Moriwaki, Jinny S Wong, Brian Hubbard, Stephen Marmor, and Robert V Farese. Deficiency of the intestinal enzyme acyl coa:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. Nature Medicine, 15(4):442–446, March 2009. URL: http://dx.doi.org/10.1038/nm.1937, doi:10.1038/nm.1937. This article has 144 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nm.1937)